BASF H1 Net Income Plummets 51 Percent to 887 Million Euros EBITDA Down 13 Percent as Chemical Prices Drag
BASF reported sales of €33.2 billion for the first half of 2025, down 1.5% year-on-year, with falling prices in four out of six business segments—especially in chemicals—putting pressure on overall results. The Nutrition & Care and Surface Technologies divisions bucked the trend with price increases, while currency headwinds impacted all areas.
EBITDA fell sharply by 13.4% to €3.7 billion, compared to €4.2 billion in the same period last year, mainly due to weaker chemical segment performance. EBIT dropped 23.4% to €1.7 billion. Net income plunged 50.6% to €887 million, versus €1.8 billion a year earlier.
Operating cash flow was €603 million, a decrease of €834 million year-on-year. Free cash flow came in at negative €1.3 billion, deepening from last year’s negative €986 million. Investment outflows shrank by €1.2 billion, largely because spending on property and equipment—especially for the Zhanjiang site in China—fell by €554 million.
Despite some positive trends in volumes for surface technologies and agricultural solutions, BASF’s overall financials were weighed down by pricing and currency pressures.
2026-08-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
Biochem to Acquire BASF’s Global Glycinates Business
-
Wanhua Resumes PO Production: How Much Can Polyether Producers Save on Costs?
-
Röhm Opens MMA Plant in Texas
-
Paint Giant PPG Announces Global Price Hike
-
Evonik and AMSilk Expand Collaboration to Develop Sustainable Biotech Silk Materials
-
Roche Keeps German Diagnostics Investment
-
Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes
-
Nippon Paint Offers $8.55 Billion for AkzoNobel’s Decorative Paints Business
-
Typhoon Bavi Hits Zhejiang and Fujian, Putting Two Major Petrochemical Hubs at Logistics Risk
Recommend Reading
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
McKinsey Pays to Close a Purdue Liability Chapter
-
Univar Solutions Expands Partnership with American Distilling in EMEA to Strengthen Natural Specialty Ingredients Distribution Network
-
Supply and Demand Struggle: Aniline Market Consolidates
-
This Week, China's Titanium Dioxide Market Trended Upward (9.1-9.5)
-
Weekend Epoxy Chloropropane Market Prices Surge Sharply (Sept. 1–5)
-
This week, the n-butanol market in Shandong, China, has stabilized after a decline
-
Premium Global Chemical Sourcing Requests (3-5July, 2026)